LXRX vs. NAK
LXRX (Lexicon Pharmaceuticals, Inc.) and NAK (Northern Dynasty Minerals Ltd.) are both stocks. LXRX operates in Biotechnology (Healthcare), while NAK operates in Other Industrial Metals & Mining (Basic Materials). Over the past 10 years, LXRX returned -18.68%/yr vs 20.11%/yr for NAK. At a 0.16 correlation, their price movements are largely independent.
Performance
LXRX vs. NAK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LXRX achieves a 60.87% return, which is significantly higher than NAK's 14.21% return. Over the past 10 years, LXRX has underperformed NAK with an annualized return of -18.68%, while NAK has yielded a comparatively higher 20.11% annualized return.
LXRX
- 1D
- -2.12%
- 1M
- 15.62%
- YTD
- 60.87%
- 6M
- 32.14%
- 1Y
- 192.72%
- 3Y*
- -12.32%
- 5Y*
- -16.06%
- 10Y*
- -18.68%
NAK
- 1D
- -5.46%
- 1M
- 8.70%
- YTD
- 14.21%
- 6M
- 16.58%
- 1Y
- 77.17%
- 3Y*
- 116.74%
- 5Y*
- 31.24%
- 10Y*
- 20.11%
LXRX vs. NAK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LXRX Lexicon Pharmaceuticals, Inc. | 60.87% | 55.72% | -51.73% | -19.90% | -51.52% | 15.20% | -17.59% | -37.50% | -32.79% | -28.56% |
NAK Northern Dynasty Minerals Ltd. | 14.21% | 238.78% | 79.86% | 46.42% | -32.31% | 1.30% | -25.12% | -24.46% | -67.84% | -14.49% |
Correlation
The correlation between LXRX and NAK is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Oct 10, 2003 | 0.16 |
Fundamentals
LXRX:
$740.44M
NAK:
$1.24B
LXRX:
-$0.07
NAK:
-$0.19
LXRX:
3.65
NAK:
69.81
LXRX:
$69.64M
NAK:
$0.00
LXRX:
$69.00M
NAK:
-$85.85K
LXRX:
-$20.38M
NAK:
-$99.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LXRX vs. NAK — Risk / Return Rank
LXRX
NAK
LXRX vs. NAK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexicon Pharmaceuticals, Inc. (LXRX) and Northern Dynasty Minerals Ltd. (NAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LXRX | NAK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +1.28 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.23 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 5.69 | 1.15 | +4.54 |
| Martin ratioReturn relative to average drawdown | 12.51 | 1.97 | +10.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LXRX | NAK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.26 | 0.68 | +1.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.38 | -0.54 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.19 | 0.21 | -0.40 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.17 | -0.01 | -0.16 |
Drawdowns
LXRX vs. NAK - Drawdown Comparison
The maximum LXRX drawdown since its inception was -99.91%, roughly equal to the maximum NAK drawdown of -99.01%. Use the drawdown chart below to compare losses from any high point for LXRX and NAK.
Loading charts...
Drawdown Indicators
| LXRX | NAK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.91% | -99.01% | -0.90% |
Max Drawdown (1Y)Largest decline over 1 year | -34.09% | -67.68% | +33.59% |
Max Drawdown (3Y)Largest decline over 3 years | -91.83% | -67.68% | -24.15% |
Max Drawdown (5Y)Largest decline over 5 years | -95.25% | -67.68% | -27.57% |
Max Drawdown (10Y)Largest decline over 10 years | -98.48% | -93.79% | -4.69% |
Current DrawdownCurrent decline from peak | -99.44% | -89.33% | -10.11% |
Average DrawdownAverage peak-to-trough decline | -93.20% | -73.91% | -19.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.48% | 39.32% | -23.84% |
Volatility
LXRX vs. NAK - Volatility Comparison
Lexicon Pharmaceuticals, Inc. (LXRX) has a higher volatility of 29.25% compared to Northern Dynasty Minerals Ltd. (NAK) at 20.00%. This indicates that LXRX's price experiences larger fluctuations and is considered to be riskier than NAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LXRX | NAK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.25% | 20.00% | +9.25% |
Volatility (6M)Calculated over the trailing 6-month period | 58.59% | 76.00% | -17.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.81% | 114.96% | -29.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.26% | 83.51% | +14.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.22% | 97.83% | -0.61% |
Dividends
LXRX vs. NAK - Dividend Comparison
Neither LXRX nor NAK has paid dividends to shareholders.
Financials
LXRX vs. NAK - Financials Comparison
This section allows you to compare key financial metrics between Lexicon Pharmaceuticals, Inc. and Northern Dynasty Minerals Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LXRX and NAK have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LXRX has higher volatility (29.25%) compared to NAK (20.00%). In terms of maximum drawdown, LXRX dropped -99.91% vs NAK's -99.01%.
LXRX currently has the higher Sharpe Ratio (2.26 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LXRX and NAK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer